Skip to main content

Table 5 Analysis of factors influencing the occurrence of toxicities patients with radiochemotherapy in LD-SCLC

From: Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting

Characteristics

Toxicity (at least 1)

OR (95% CI)

p

Age

1.0 (0.9–1.1)

0.45

Sex

 Male

Ref.

 Female

0.2 (0.0–1.0)

0.04

Karnofsky

 80–100

Ref.

 < 80

1.0 (0.3–4.1)

0.96

Start during cycle

 Early start

Ref.

 Late start

0.9 (0.2–4.5)

0.94

 Very late start

1.0 (0.1–9.0)

0.98

Mean lung dose

1.4 (1.1–1.8)

0.01

PTV

1.0 (1.0–1.0)

0.17